Cerus Corp. (NSDQ:CERS) announced today that it received FDA approval for its Intercept plasma with an alternative plastic disposable kit. The company’s conversion to the new disposable kit represents its strategy to enhance its global supply chain’s integrity, according to a news release. The approval is a prerequisite for the company’s planned PMA-S submission for […]
Here at MassDevice — medtech's online business journal — we're covering news about the coronavirus (COVID-19) pandemic daily. Here is the latest about coronavirus and the medical device industry, regulatory changes related to the pandemic, new tests for the virus, vaccine development, and much more.
New bill would provide $75B for PPE, ventilator production
A bill by two progressive Congressional Democrats would provide the federal government with $75 billion to produce or purchase personal protective equipment (PPE) and medical devices to fight the COVID-19 pandemic. Sen. Bernie Sanders (I-Vt.) and Rep. Ro Khanna (D-Calif.) are co-sponsoring the bill, which aims to provide the money to the Federal Emergency Management […]
Tactile Systems up despite 1Q losses
Tactile Systems Technology (NSDQ: TCMD) shares crept up today on mixed first-quarter results that included a slide from profits to losses. The Minneapolis-based company posted losses of -$1.3 million, or -7¢ per share, on sales of $43.7 million for the three months ended March 31, 2020, for a bottom-line into the red from profits of $1.5 million […]
BREAKING: FDA grants emergency use of drug to treat COVID-19
The FDA this afternoon issued an emergency use authorization for the investigational antiviral drug remdesivir to treat severely ill COVID-19 patients. The authorization for the drug, made by Gilead Sciences’ (NSDQ:GILD), will allow both adults and children to be treated with the remdesivir, the first drug believed to have any effect on the virus that has […]
DeviceTalks Weekly: Ep. 8 – AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 VC data
In this week’s episode of DeviceTalks Weekly, Scott Whitaker, CEO and president of AdvaMed, shares concerns he had over how the federal government would work with the medtech industry during the pandemic crisis. Does he feel the medtech industry was treated fairly? How does he see the federal government and medtech industry working together in […]
ResMed up on revenues boosted by ventilator sales
ResMed (NYSE:RMD) shares ticked up today on third-quarter results that topped the consensus forecast with COVID-19-influenced demand for ventilators. The San Diego-based company posted profits of $163.1 million, or $1.12 per share, on sales of $769.5 million for the three months ended March 31, 2020, for a 54.7% bottom-line gain on sales growth of 16.2%. Adjusted […]
Stryker beats The Street on Q1 results, warns of significant COVID-19 impact
Stryker (NYSE:SYK) shares dropped slightly today on first-quarter results that came in ahead of the consensus forecast. The Kalamazoo, Mich.-based orthopedic device company posted profits of $493 million, or $1.30 per share, on sales of $3.6 billion for the three months ended March 31, 2020, for a 19.7% bottom-line gain on sales growth of 2%. Adjusted […]
NASA-developed ventilator receives EUA
The FDA granted emergency use authorization (EUA) to a ventilator developed by NASA that is tailored for treating patients with COVID-19. NASA engineers developed the “ventilator intervention technology accessible locally” device, called “VITAL,” at NASA’s Jet Propulsion Laboratory in Southern California in an effort to free up traditional ventilators for use on patients with the […]
Teleflex beats The Street on sales, posts sharply higher profits
Shares in Teleflex (NYSE:TFX) dropped nearly 4% today, despite a first-quarter 2020 report that revealed Street-beating sales and skyrocketing profits. The Wayne, Pa.-based surgical and critical care device maker posted profits of $131.15 million, or $2.83 per share on sales of $630.64 million for the three months ended March 29, 2020, for a 220.68% bottom-line gain […]
Baxter beats The Street in Q1
Baxter (NYSE:BAX) shares ticked up slightly today on first-quarter results that topped the consensus forecast, despite a slight drop in year-over-year profits. The Deerfield, Ill.-based company posted profits of $333 million, or 64¢ per share, on sales of $2.8 billion for the three months ended March 31, 2020, for a 2.6% bottom-line slide on sales growth […]
Fauci: Hundreds of millions of COVID-19 vaccine doses could be ready in January
Dr. Anthony Fauci said this morning that hundreds of millions of doses of a vaccine for COVID-19 could be ready by January. In an interview on the Today Show, the director of the National Institute of Allergy and Infectious Diseases said that a vaccine candidate is in the first phase of a clinical trial. If […]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 32
- Next Page »
